YARROW BIOSCIENCE INC
Public company snapshot, recent ticker-linked headlines, and a path into evidence-backed AI research.
Latest price
$19.90
-0.50%
Alpha Vantage · 10/30/2026
One-year price history
Adjusted daily closes · 252 observations · as of Oct 30, 2026
1 month
-15.7%
3 months
-40.8%
6 months
+11.1%
1 year
+94.5%
Year to date
+22.9%
52-week range
$9.15 – $42.94
Fundamental snapshot
Latest reported period: Jun 30, 2026
Market cap
$53.1M
P/E
-2.8
P/B
2.4
P/S
110.2
Revenue
$482K
Net income
-$18.71M
Diluted EPS
-21.51
Gross margin
100.00%
Net margin
-3881.50%
Return on equity
-70.20%
Total debt
$0
Cash
$22.93M
Free cash flow
-$16.93M
Latest eight reported quarters
Reported quarterly values, newest first
| Period | Revenue | Net income | Gross margin | Net margin | Free cash flow |
|---|---|---|---|---|---|
| Jun 30, 2026 | $97K | -$3.01M | 100.00% | -3100.00% | -$1.99M |
| Mar 31, 2026 | $86K | -$3.59M | 100.00% | -4168.60% | -$4.08M |
| Dec 31, 2025 | $130K | -$4.84M | 100.00% | -3720.80% | -$3.76M |
| Sep 30, 2025 | $169K | -$7.28M | 100.00% | -4307.70% | -$7.1M |
| Jun 30, 2025 | $69K | -$5.76M | 100.00% | -8340.60% | -$10.8M |
| Mar 31, 2025 | $202K | -$8.61M | 100.00% | -4262.90% | -$11.46M |
| Dec 31, 2024 | $84K | -$12.02M | 100.00% | -14311.90% | -$9.12M |
| Sep 30, 2024 | $121K | -$12.16M | 100.00% | -10047.10% | -$8.51M |
Reported figures can reflect company reporting conventions, restatements, or sector-specific accounting. Verify against filings before relying on a valuation comparison.
Recent YARW news
All market newsNo ticker-linked stories are in the current archive.